Nanoparticle-guided brain drug delivery: Expanding the therapeutic approach to neurodegenerative diseases
C Riccardi, F Napolitano, D Montesarchio, S Sampaolo… - Pharmaceutics, 2021 - mdpi.com
Neurodegenerative diseases (NDs) represent a heterogeneous group of aging-related
disorders featured by progressive impairment of motor and/or cognitive functions, often …
disorders featured by progressive impairment of motor and/or cognitive functions, often …
Strategies of engineering nanoparticles for treating neurodegenerative disorders
K Tu Nguyen, M Nguyet Pham, T Van Vo… - Current Drug …, 2017 - ingentaconnect.com
Background: Neurodegenerative disorders (NDs) are typically referred to Alzheimer's
disease, Parkinson's diseases, amyotrophic lateral sclerosis and prion disease. These are …
disease, Parkinson's diseases, amyotrophic lateral sclerosis and prion disease. These are …
Neurotherapeutic applications of nanoparticles in Alzheimer's disease
A rapid increase in incidence of neurodegenerative disorders has been observed with the
aging of the population. Alzheimer's disease (AD) is the most common neurodegenerative …
aging of the population. Alzheimer's disease (AD) is the most common neurodegenerative …
Recent advances in biomimetic nanodelivery systems: new brain-targeting strategies
J Liao, L Fan, Y Li, QQ Xu, LY Xiong, SS Zhang… - Journal of Controlled …, 2023 - Elsevier
In recent years, brain diseases have seriously threatened human health due to their high
morbidity and mortality. Achieving efficient drug delivery to provide satisfactory therapeutic …
morbidity and mortality. Achieving efficient drug delivery to provide satisfactory therapeutic …
Drug delivery to the brain across the blood–brain barrier using nanomaterials
A major obstacle facing brain diseases such as Alzheimer's disease, multiple sclerosis,
brain tumors, and strokes is the blood–brain barrier (BBB). The BBB prevents the passage of …
brain tumors, and strokes is the blood–brain barrier (BBB). The BBB prevents the passage of …
Nanoscience in targeted brain drug delivery
Neurological diseases are one of the most serious life-threatening diseases worldwide. The
currently applied strategies for the treatment of neurological diseases are not able to provide …
currently applied strategies for the treatment of neurological diseases are not able to provide …
Targeted delivery of nano-therapeutics for major disorders of the central nervous system
Major central nervous system (CNS) disorders, including brain tumors, Alzheimer's disease,
Parkinson's disease, and stroke, are significant threats to human health. Although …
Parkinson's disease, and stroke, are significant threats to human health. Although …
Alzheimer's disease targeted nano-based drug delivery systems
G Altinoglu, T Adali - Current Drug Targets, 2020 - ingentaconnect.com
Alzheimer's disease (AD) is the most common neurodegenerative disease, and is part of a
massive and growing health care burden that is destroying the cognitive function of more …
massive and growing health care burden that is destroying the cognitive function of more …
[HTML][HTML] Nanoparticle-mediated brain drug delivery: overcoming blood–brain barrier to treat neurodegenerative diseases
The blood–brain barrier (BBB) is a vital boundary between neural tissue and circulating
blood. The BBB's unique and protective features control brain homeostasis as well as ion …
blood. The BBB's unique and protective features control brain homeostasis as well as ion …
A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics
Neurodegenerative disorders are primarily characterized by neuron loss. The most common
neurodegenerative disorders include Alzheimer's and Parkinson's disease. Although there …
neurodegenerative disorders include Alzheimer's and Parkinson's disease. Although there …